Exon-skipping drugs present a critical test for the FDA’s goal of encouraging treatments for rare disease.
Back to Lifestyle
Lifestyle
October 7, 2026 at 8:30 AM
STAT+: In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few
STAT News
Excerpt from STAT News.